Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 41 publications
CDK4/6 inhibitors rechallenge post-progression in HR-positive HER2-negative advanced/metastatic breast cancer patients: a meta-analysis of Kaplan-Meier-reconstructed individual-level data.
Journal: Breast cancer research : BCR
Published: January 13, 2026
MITF Gain-of-Function Mutation in Metastatic Prostate Cancer: A Rare Finding With Potential Therapeutic Significance.
Journal: Cancer reports (Hoboken, N.J.)
Published: September 29, 2025
MITF Gain-of-Function Mutation in Metastatic Prostate Cancer: A Rare Finding With Potential Therapeutic Significance.
Journal: Cancer reports (Hoboken, N.J.)
Published: September 29, 2025
Corrigendum to "Trastuzumab deruxtecan in human epidermal growth factor receptor 2-positive breast cancer brain metastases: A systematic review and updated meta-analysis" [Cancer Treat. Rev. 133 (2025) 102882].
Journal: Cancer treatment reviews
Published: July 16, 2025
Focused Ultrasound for Sarcomas: A Narrative Review.
Journal: Current oncology (Toronto, Ont.)
Published: June 30, 2025
Emerging IO checkpoints in gastrointestinal oncology.
Journal: Frontiers in immunology
Published: February 12, 2025
Safety and Efficacy of Osimertinib in Patients With Non-Small-Cell Lung Cancer and Uncommon Tumoral Epidermal Growth Factor Receptor Mutations: A Systematic Review and Single-Arm Meta-Analysis.
Journal: JCO precision oncology
Published: November 22, 2024
Trastuzumab deruxtecan in human epidermal growth factor receptor 2-positive breast cancer brain metastases: A systematic review and updated meta-analysis.
Journal: Cancer treatment reviews
Published: November 20, 2024
Antibody-drug conjugates in patients with advanced/metastatic HER2-low-expressing breast cancer: a systematic review and meta-analysis.
Journal: Therapeutic advances in medical oncology
Published: September 07, 2024
Phase II study of elraglusib (9-ING-41), a GSK-3β inhibitor, in combination with gemcitabine plus nab-paclitaxel in previously untreated metastatic pancreatic cancer.
Journal: ESMO open
Published: August 23, 2024
Last Updated: 09/26/2026